Teva Enhances Extensive Women's Health Portfolio with Launch of Generic ...
Oral contraceptives should not be used in women who currently have the following conditions: thrombophlebitis or thromboembolic disorders; a past history of deep vein thrombophlebitis or thromboembolic disorders; cerebrovascular or coronary artery ...
Finances.com - Fri, 29 May 2015 05:34

Some Immune Cells Change To Prolong Inflammation
But the researchers found that, during oral thrush, yeast sugars on the surface of the disease-causing fungus act as a binding agent and can activate a small population of Treg cells to make inflammatory proteins themselves. (The researchers are ...
Science 2.0 - Wed, 27 May 2015 06:18



Leukoplakia, causes, symptoms and treatments
During the biopsy, a small tissue from the lesion is removed and examined in a laboratory condition. In general, it is diagnosed with the help of an oral exam. Sometimes patients mistake it with the condition known as oral thrush. But the patches ...
Doctor Tipster - Tue, 26 May 2015 07:26

Research: Some immune cells convert into cells that trigger disease
But the researchers found that, during oral thrush, yeast sugars on the surface of the disease-causing fungus act as a binding agent and can activate a small population of Treg cells to make inflammatory proteins themselves. (The researchers are ...
News-Medical.net - Fri, 22 May 2015 05:45

Public Release: 21-May-2015 CWRU dental researchers find some immune ...
But the researchers found that, during oral thrush, yeast sugars on the surface of the disease-causing fungus act as a binding agent and can activate a small population of Treg cells to make inflammatory proteins themselves. (The researchers are ...
EurekAlert (press release) - Thu, 21 May 2015 08:11

Yeast and Fungus Among Us: Tinea and Candida Infections of the Skin
Antibiotic use or immune system dysfunction creates opportunities for oral, digestive, or vaginal overgrowth. Candida fungi prefer moist areas, making Candida a common cause of diaper rash, rash in obese patients' skin folds, and vaginal infections ...
Pharmacy Times - Wed, 13 May 2015 14:33

FDA approves BREO® ELLIPTA® for the treatment of adults with asthma in the US
... and oral candidiasis, 5% (2%). In addition to the reactions reported in the 6-month studies, adverse reactions occurring in >3% of the subjects treated with Breo Ellipta 100/25 in two 1-year studies included back pain, pneumonia, bronchitis ...
MarketWatch - Thu, 30 Apr 2015 13:37

DARA BioSciences' (DARA) CEO Christopher Clement on Q1 2015 Results ...
... that during the first quarter DARA signed an exclusive licensing agreement with on sale SA, France for the US rights to the NDA for Oravig the first and only orally dissolving buccal tablet formulation of miconazole approved for the treatment of ...
Seeking Alpha - Thu, 14 May 2015 13:35


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014